Undated — "As a Skeletal Muscle Relaxant" (Valium)
Roche Laboratories
Straightforward trade-journal clinical copy — none of the domestic/gendered framing of the earlier Butisol or Miltown ads. Pitches Valium's muscle-relaxant indication (spasticity, upper motor neuron disorders, cerebral palsy) alongside its anxiolytic use, with an unusually blunt aside: "patients should be cautioned against driving or drinking alcohol while on Valium. Periodic reassessment of the need for a psychotropic agent is also recommended" — a rare moment of a manufacturer flagging its own product's long-term-use risk within the ad copy itself.
1971 — "Her World Orbits Around Doctors" (Valium)
Roche Laboratories, Nutley NJ
Perhaps the single most elaborate psychologising ad in the entire collection. A "childless widow" is sociometrically diagrammed against seven male specialists and her deceased husband/father, mother, and sister — her grief, hypochondriasis, and family estrangement reduced to a diagram of "dominance, closeness, absence, and loss." The copy explicitly instructs the physician to redirect her "somatic concerns" toward "old, hidden problem areas" while medicating the "psychic tension" underneath with Valium. A masterclass in reframing bereavement and family conflict as a diagnosable, treatable condition — extending the "battered parent"/"tired housewife" playbook to widowhood itself.
Undated — "She Can Be Reached at Home" (Mellaril / thioridazine)
Sandoz Pharmaceuticals, Hanover NJ
A tiny elderly woman, mop and bucket in hand, held in a giant open palm. Pitches thioridazine as a maintenance drug precisely because it doesn't sedate or diminish drive enough to interfere with a discharged patient's domestic/institutional labour — "reduces many of the psychological hazards of the uncontrolled environment" reads as code for keeping deinstitutionalised patients docile and functional enough to keep working, at home or in a facility, without the extrapyramidal side effects that would visibly mark them as medicated.
1993 — "For Anxiety With Associated Depressive Symptoms" (Xanax)
The Upjohn Company
A stylistic outlier — abstract Pollock-esque paint-splatter design rather than a staged photo, signalling a shift toward lifestyle/abstract pharmaceutical branding as the SSRI/benzodiazepine era matured. Notably terse copy by comparison with the Valium and Miltown ads: no narrative, no case study, just indication and pill images. By 1993, the "invented syndrome" storytelling style of the 1970s had given way to cleaner, more clinical positioning — though the underlying indication (anxiety with depressive symptoms) still leans on the same blurred-boundary diagnostic category used throughout this collection.
c.1900 — "This is Cube Morphine" (Sulphate of Morphine)
New York Quinine & Chemical Works, in American Druggist and Pharmaceutical Record
Trade-journal advertising aimed at pharmacists and physicians rather than consumers, pitching "Cube Morphine" — a specific tableted/compressed form — on purity and dosing safeguards ("the purity of the product and the safeguard of its form have appealed successfully to Physicians and Pharmacists"). The skull-and-crossbones poison marking on the bottle itself is a genuine period safety convention, not a warning added for this collection — full-strength morphine sulphate was legitimately labelled as a poison even while being actively marketed for wide prescribing.